Steven Ketchum

Steven Ketchum

Chief Tech/Sci/R&D Officer at AMARIN CORPORATION PLC

Net worth: 13 M $ as of 2026-07-30

61 year
Health Technology
Consumer Services

Profile

Steven B. Ketchum is Chief Scientific Officer, EVP, President-R&D at Amarin Corp.
Plc since 2012.
Formerly, Dr. Ketchum was Senior Director-Regulatory Affairs at ALZA Corp.
from 1994 to 2002, Senior VP-Operations & Regulatory Affairs at IntraBiotics Pharmaceuticals, Inc. from 2002 to 2007, Senior VP-Medical Affairs, Research & Development at Reliant Pharmaceuticals LLC from 2005 to 2008, and Independent Director at Sunesis Pharmaceuticals, Inc. from 2012 to 2021.
Education includes undergraduate studies at Stanford University and a doctorate from University College London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-30 853,600 ( 0.21% ) 12 M $ 2026-07-30
2025-01-30 37,350 ( 0.18% ) 532 611 $ 2026-07-30

Steven Ketchum active positions

CompaniesPositionStart
AMARIN CORPORATION PLC Chief Tech/Sci/R&D Officer 2012-02-15

Former positions of Steven Ketchum

CompaniesPositionEnd
VIRACTA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2012-01-31
Chief Tech/Sci/R&D Officer 2008-04-30
Chief Operating Officer 2007-01-21
ALZA CORPORATION General Counsel 2002-04-30
See the detail of Steven Ketchum's experience

Training of Steven Ketchum

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Steven Ketchum